Biomarker-Aware Super-Resolution for 4D Flow MRI in a Synthetic Pulmonary-Artery Benchmark
- 1CIC biomaGUNE, BRTA, San Sebastian, Spain; Universidad del Pais Vasco, Leioa, Spain
Abstract
Purpose: To evaluate, within a synthetic pulmonary-artery benchmark, whether biomarker-aware super-resolution improves hemodynamic endpoint fidelity in 4D flow MRI. Methods: A 3D residual channel attention network (RCAN) was trained on 22 CFD simulations from 11 pulmonary-artery geometries with 2x spatial degradation. The original primary comparison evaluated full biomarker-aware training against a combined divergence-temporal-regularization control across 14 matched seeds on a fixed six-case test set. Additional matched analyses subsequently separated divergence and adjacent-frame temporal-difference regularization and evaluated biomarker supervision in a controlled 2x2 design with a common reconstruction schedule. Results: In the original primary comparison, biomarker-aware training reduced PI error relative to the matched combined-regularization control (12.76 +/- 2.34% vs. 17.12 +/- 1.23%; paired difference -4.35 percentage points [95% CI -5.58, -3.09]; p = 0.0015). In the matched factorial analysis, biomarker supervision reduced PI error without (-2.235 percentage points [95% CI -3.514, -0.849]) and with (-4.125 percentage points [95% CI -5.392, -2.732]) combined regularization. PI improvement was not mirrored by uniformly improved reconstruction metrics: PSNR changed by -0.058 (p = 0.50) and +0.144 dB (p = 0.28), while SSIM decreased by 0.009 (p = 0.004) and 0.007 (p = 0.009), respectively. Divergence alone changed PI by +0.034 percentage points [95% CI -0.705, 0.809] while reducing DivRMS by 1.869 percentage points; temporal-difference regularization increased PI error by 1.562 percentage points [95% CI 0.594, 2.439]. Conclusion: Within this synthetic, fixed-case RCAN benchmark, biomarker supervision improved PI under both regularization conditions. PI improvement was not mirrored by uniformly improved reconstruction metrics. Temporal-difference - not divergence - regularization was the only isolated component associated with reproducible PI deterioration. These findings are configuration-specific and require geometry-independent and in vivo validation.
Related
- 1100 synthetic benchmark problems for dynamic modeling of cellular processes.
- Separating benchmark discrimination from experimental retrieval in synthetic-lethality prediction
- A community benchmark enables high-resolution, cross-lab quantification of mouse social behavior
- Case Report: transient migratory pulmonary nodules with bronchial artery malformations in an autosomal dominant polycystic kidney disease patient: a case of recurrent hemoptysis.
- BiNVaST: niche boundary-preserving and synthetic data-guided variational autoencoders for concordant inference across high-resolution spatial transcriptomic platforms
BibTeX
@misc{zubillagaunsain2026biomarkeraware,
title = {{Biomarker-Aware Super-Resolution for 4D Flow MRI in a Synthetic Pulmonary-Artery Benchmark}},
author = {A. Zubillaga-Unsain and A. Lluveras-Sires and C. Caballero-Gaudes and J. Ruiz-Cabello},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.25.754495},
url = {https://www.biorxiv.org/content/10.64898/2026.09.25.754495v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Biomarker-Aware Super-Resolution for 4D Flow MRI in a Synthetic Pulmonary-Artery Benchmark
AU - A. Zubillaga-Unsain
AU - A. Lluveras-Sires
AU - C. Caballero-Gaudes
AU - J. Ruiz-Cabello
PY - 2026
DA - 2026/09/25
PB - bioRxiv
DO - 10.64898/2026.09.25.754495
UR - https://www.biorxiv.org/content/10.64898/2026.09.25.754495v1
AB - Purpose: To evaluate, within a synthetic pulmonary-artery benchmark, whether biomarker-aware super-resolution improves hemodynamic endpoint fidelity in 4D flow MRI. Methods: A 3D residual channel attention network (RCAN) was trained on 22 CFD simulations from 11 pulmonary-artery geometries with 2x spatial degradation. The original primary comparison evaluated full biomarker-aware training against a combined divergence-temporal-regularization control across 14 matched seeds on a fixed six-case test set. Additional matched analyses subsequently separated divergence and adjacent-frame temporal-difference regularization and evaluated biomarker supervision in a controlled 2x2 design with a common reconstruction schedule. Results: In the original primary comparison, biomarker-aware training reduced PI error relative to the matched combined-regularization control (12.76 +/- 2.34% vs. 17.12 +/- 1.23%; paired difference -4.35 percentage points [95% CI -5.58, -3.09]; p = 0.0015). In the matched factorial analysis, biomarker supervision reduced PI error without (-2.235 percentage points [95% CI -3.514, -0.849]) and with (-4.125 percentage points [95% CI -5.392, -2.732]) combined regularization. PI improvement was not mirrored by uniformly improved reconstruction metrics: PSNR changed by -0.058 (p = 0.50) and +0.144 dB (p = 0.28), while SSIM decreased by 0.009 (p = 0.004) and 0.007 (p = 0.009), respectively. Divergence alone changed PI by +0.034 percentage points [95% CI -0.705, 0.809] while reducing DivRMS by 1.869 percentage points; temporal-difference regularization increased PI error by 1.562 percentage points [95% CI 0.594, 2.439]. Conclusion: Within this synthetic, fixed-case RCAN benchmark, biomarker supervision improved PI under both regularization conditions. PI improvement was not mirrored by uniformly improved reconstruction metrics. Temporal-difference - not divergence - regularization was the only isolated component associated with reproducible PI deterioration. These findings are configuration-specific and require geometry-independent and in vivo validation.
ER -